Analyze Diet
Equine veterinary education2020; 33(4); 215-219; doi: 10.1111/eve.13308

Safety and efficacy of subcutaneous alpha-tocopherol in healthy adult horses.

Abstract: Vitamin E is essential for neuromuscular function. The primary treatment, oral supplementation with natural ('RRR') α-tocopherol, is not effective in all horses. The objectives of this pilot study were to evaluate the safety and efficacy of a subcutaneously administered RRR-α-tocopherol preparation. Horses were randomly assigned in a cross-over design to initially receive RRR-α-tocopherol (5000 IU/450 kg of 600 IU/mL) subcutaneously (n = 3) or orally (n = 3) or were untreated sentinels (n = 2). Tissue reactions following injection in Phase I of the study necessitated adjustment of the preparation with reduction of the RRR-α-tocopherol concentration to 500 IU/mL in Phase 2. Following an 8-week washout period, horses received the reciprocal treatment route with the new preparation (5000 IU/450 kg of 500 IU/mL). Serum, CSF and muscle α-tocopherol concentrations were determined by high-performance liquid chromatography over a 14-day period during each phase. Serum and CSF α-tocopherol concentrations increased significantly postinjection only when the 500 IU/mL product was administered (P<0.0001). There was no significant difference in the muscle concentration of α-tocopherol following either treatment. All eight horses had marked tissue reaction to subcutaneous injection, regardless of product concentration. Whilst we have demonstrated that this route may be a useful alternative to oral supplementation, the marked tissue reaction makes use of such products limited at this time to only the most refractory of cases.
Publication Date: 2020-06-04 PubMed ID: 34326575PubMed Central: PMC8315600DOI: 10.1111/eve.13308Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article discusses a pilot study conducted to observe the safety and effectiveness of subcutaneous administration of RRR-α-tocopherol, a naturally sourced form of Vitamin E, to healthy adult horses. The study was initiated because oral supplementation of this vitamin doesn’t seem to work effectively for all equines, necessitating the exploration of other options.

Research Methodology:

  • Healthy adult horses were randomly assigned to groups, with three receiving subcutaneous injections of RRR-α-tocopherol, three given the same vitamin orally, and two untreated as control or “sentinel” horses.
  • Researchers noticed tissue reactions after injection in the first phase of the study, which led them to readjust the preparation by reducing the RRR-α-tocopherol concentration to 500IU/mL in the second phase.
  • An 8-week washout period followed, after which horses received the opposite treatment route (those initially subcutaneously injected received oral supplement and vice versa) with the new preparation.
  • Over a 14-day period during each phase, concentrations of α-tocopherol in horse serum, cerebrospinal fluid (CSF), and muscle were determined using high-performance liquid chromatography (HPLC).

Findings and Conclusion:

  • Serum and CSF α-tocopherol concentrations increased significantly post-injection, but this was only when the 500 IU/mL product was administered.
  • There was no significant difference in muscle α-tocopherol concentrations following either type of treatment (oral or injected).
  • Notably, all eight horses experienced a distinct tissue reaction to the subcutaneous injection, regardless of the product concentration used.
  • The findings highlight that while the subcutaneous administration route of RRR-α-tocopherol may be a useful alternative to oral supplementation, the pronounced tissue reactions impose a limitation on the use of such products to only the most refractory of cases.

Cite This Article

APA
Donnelly CG, Burns E, Easton-Jones CA, Katzman S, Stuart R, Cook SE, Finno CJ. (2020). Safety and efficacy of subcutaneous alpha-tocopherol in healthy adult horses. Equine Vet Educ, 33(4), 215-219. https://doi.org/10.1111/eve.13308

Publication

ISSN: 0957-7734
NlmUniqueID: 9885274
Country: England
Language: English
Volume: 33
Issue: 4
Pages: 215-219

Researcher Affiliations

Donnelly, C G
  • William R. Pritchard Veterinary Medical Teaching Hospital.
Burns, E
  • Morris Animal Foundation, Denver, Colorado.
Easton-Jones, C A
  • Rossdales Equine Hospital, Exning, UK.
Katzman, S
  • Department of Surgical and Radiological Sciences, University of California: Davis, Davis.
Stuart, R
  • Stuart Products Inc, Bedford, Texas.
Cook, S E
  • Department of Pathology, Microbiology and Immunology, University of California: Davis, Davis, USA.
Finno, C J
  • William R. Pritchard Veterinary Medical Teaching Hospital.
  • Department of Population Health and Reproduction.

Grant Funding

  • L40 TR001136 / NCATS NIH HHS

Conflict of Interest Statement

Authors’ declaration of interests R. Stuart is the director and owner of Stuart Products which produces nutritional products.

References

This article includes 19 references
  1. Alvinerie M, Escudero E, Sutra JF, Eeckhoutte C, Galtier P. The pharmacokinetics of moxidectin after oral and subcutaneous administration to sheep.. Vet Res 1998 Mar-Apr;29(2):113-8.
    pubmed: 9601143
  2. Brown JC, Valberg SJ, Hogg M, Finno CJ. Effects of feeding two RRR-α-tocopherol formulations on serum, cerebrospinal fluid and muscle α-tocopherol concentrations in horses with subclinical vitamin E deficiency.. Equine Vet J 2017 Nov;49(6):753-758.
    doi: 10.1111/evj.12692pmc: PMC5640495pubmed: 28432750google scholar: lookup
  3. Desmarchelier C, Borel P. Bioavailability of Vitamin E. Physiology of the Gastrointestinal Tract: Sixth Edition Sixth Edition, Vol. 2–2.
  4. Díez de Castro E, Zafra R, Acevedo LM, Pérez J, Acosta I, Rivero JL, Aguilera-Tejero E. Eosinophilic Enteritis in Horses with Motor Neuron Disease.. J Vet Intern Med 2016 May;30(3):873-9.
    doi: 10.1111/jvim.13944pmc: PMC4913563pubmed: 27015868google scholar: lookup
  5. Finno CJ, Valberg SJ. A comparative review of vitamin E and associated equine disorders.. J Vet Intern Med 2012 Nov-Dec;26(6):1251-66.
  6. Finno CJ, Higgins RJ, Aleman M, Ofri R, Hollingsworth SR, Bannasch DL, Reilly CM, Madigan JE. Equine degenerative myeloencephalopathy in Lusitano horses.. J Vet Intern Med 2011 Nov-Dec;25(6):1439-46.
  7. Finno CJ, Estell KE, Katzman S, Winfield L, Rendahl A, Textor J, Bannasch DL, Puschner B. Blood and Cerebrospinal Fluid α-Tocopherol and Selenium Concentrations in Neonatal Foals with Neuroaxonal Dystrophy.. J Vet Intern Med 2015 Nov-Dec;29(6):1667-75.
    doi: 10.1111/jvim.13618pmc: PMC4831564pubmed: 26391904google scholar: lookup
  8. Hidiroglou M, Karpinski K. Vitamin E kinetics in sheep.. Br J Nutr 1987 Jul;58(1):113-25.
    doi: 10.1079/bjn19870075pubmed: 3620433google scholar: lookup
  9. Hidiroglou M, Karpinski K. Pharmacokinetic disposition in sheep of various vitamin E preparations given orally or intravenously.. Br J Nutr 1988 May;59(3):509-18.
    doi: 10.1079/bjn19880060pubmed: 3395610google scholar: lookup
  10. Hidiroglou M, Karpinski K. Disposition kinetics and dosage regimen of vitamin E administered intramuscularly to sheep.. Br J Nutr 1991 May;65(3):465-73.
    doi: 10.1079/bjn19910105pubmed: 1878360google scholar: lookup
  11. Irías-Mata A, Sus N, Flory S, Stock D, Woerner D, Podszun M, Frank J. α-Tocopherol transfer protein does not regulate the cellular uptake and intracellular distribution of α- and γ-tocopherols and -tocotrienols in cultured liver cells.. Redox Biol 2018 Oct;19:28-36.
    doi: 10.1016/j.redox.2018.07.027pmc: PMC6082990pubmed: 30098456google scholar: lookup
  12. Jørgensen E, Lazzarini G, Pirone A, Jacobsen S, Miragliotta V. Normal microscopic anatomy of equine body and limb skin: A morphological and immunohistochemical study.. Ann Anat 2018 Jul;218:205-212.
    doi: 10.1016/j.aanat.2018.03.010pubmed: 29730469google scholar: lookup
  13. Knight ME, Roberts RJ. Tissue vitamin E levels in newborn rabbits after pharmacologic dosing. Influence of dose, dosage form, and route of administration.. Dev Pharmacol Ther 1985;8(2):96-106.
    pubmed: 3996166doi: 10.1159/000457027google scholar: lookup
  14. Krystel-Whittemore M, Dileepan KN, Wood JG. Mast Cell: A Multi-Functional Master Cell.. Front Immunol 2015;6:620.
    doi: 10.3389/fimmu.2015.00620pmc: PMC4701915pubmed: 26779180google scholar: lookup
  15. Lodge JK, Hall WL, Jeanes YM, Proteggente AR. Physiological factors influencing vitamin E biokinetics.. Ann N Y Acad Sci 2004 Dec;1031:60-73.
    doi: 10.1196/annals.1331.006pubmed: 15753134google scholar: lookup
  16. Ronéus BO, Hakkarainen RV, Lindholm CA, Työppönen JT. Vitamin E requirements of adult Standardbred horses evaluated by tissue depletion and repletion.. Equine Vet J 1986 Jan;18(1):50-8.
  17. Snow DH, Guy PS. Percutaneous needle muscle biopsy in the horse.. Equine Vet J 1976 Oct;8(4):150-5.
  18. Stowe HD. A-Tocopherol Requirements for Equine Erythrocyte Stability. The American Journal of Clinical Nutrition 21, 135–142.
  19. Pusterla N, Puschner B, Steidl S, Collier J, Kane E, Stuart RL. alpha-Tocopherol concentrations in equine serum and cerebrospinal fluid after vitamin E supplementation.. Vet Rec 2010 Mar 20;166(12):366-8.
    doi: 10.1136/vr.b4802pubmed: 20305293google scholar: lookup

Citations

This article has been cited 1 times.
  1. Kahn SK, Cywes-Bentley C, Blodgett GP, Canaday NM, Turner-Garcia CE, Vinacur M, Cortez-Ramirez SC, Sutter PJ, Meyer SC, Bordin AI, Vlock DR, Pier GB, Cohen ND. Antibody activities in hyperimmune plasma against the Rhodococcus equi virulence -associated protein A or poly-N-acetyl glucosamine are associated with protection of foals against rhodococcal pneumonia. PLoS One 2021;16(8):e0250133.
    doi: 10.1371/journal.pone.0250133pubmed: 34437551google scholar: lookup